Search results
14 de may. de 2024 · En base a la documentación consultada, la técnica de rescate celular (“salva células” o “cell salvage”) intraoperatorio parece ser segura en pacientes con cáncer que se someten a cirugía oncológica. Su uso no parece asociarse a una menor supervivencia o a un aumento de la recurrencia del cáncer, aunque la evidencia ...
14 de may. de 2024 · Autologous blood transfusion refers to the collection of blood from a patient and its re-transfusion into the same individual at a later time. 26 Three main techniques for autologous transfusion are—predeposit autologous donation (PAD), acute normovolaemic hemodilution (ANH), and perioperative cell salvage (PCS). 27 PAD involves drawing blood from the patient weeks before planned surgery ...
27 de abr. de 2024 · Cell Salvage use holds high potential for reducing healthcare costs and indirectly contributing to improving blood and blood product reserves within blood banks. Results obtained thus far do not provide definitive evidence regarding the duration of hospital stay, ICU stay, need for reoperation, or the quantity of transfused platelets.
6 de may. de 2024 · Primary outcomes included intraoperative blood product transfusion volumes for pRBC, FFP, cryoprecipitate, autologous blood salvage, and platelets. Secondary outcomes included CPB time, ICU length of stay, and post-bypass VIS.
27 de abr. de 2024 · Postoperatively, (a) use blood/cell salvage, (b) tolerate anemia (as described later in this chapter), (c) optimize fluid and volume management, and (d) restrict diagnostic phlebotomy. The units of blood potentially saved by not doing a transfusion with each strategy are shown in Table 18-1 . 3
4 de may. de 2024 · The primary outcome was the volume of blood products transfused intraoperatively. Patients who underwent bridge to transplantation using the Impella 5.5 had a statistically significant lower median transfusions of cryoprecipitate (155mL versus 200mL p=0.015), autologous blood salvage (675mL versus 1125mL p=<0.01), and platelets ...
Hace 1 día · Therefore, 200 mg of sintilimab (a recombinant human IgG4 monoclonal antibody against PD-1) was administered as a salvage treatment with the prior informed consent of the patient. The viral copy numbers in blood and stool both decreased gradually and finally became negative 3 weeks later (Fig. 1).
